NCT00653341View on ClinicalTrials.gov

Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)

PHASE3CompletedINTERVENTIONAL
Enrollment

764

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

insulin glargine

DRUG

NPH human insulin

Trial Locations (2)

08807

Sanofi-aventis administrative office, Bridgewater

Unknown

Sanofi-aventis administrative office, Laval

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00653341 - Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s) | Biotech Hunter | Biotech Hunter